This work presents the advance to development of an algorithm for automatic detection of demyelinating lesions and cerebral ischemia through magnetic resonance images, which have contributed in paramount importance in the diagnosis of brain diseases. The sequences of images to be used are T1, T2, and FLAIR. Brain demyelination lesions occur due to damage of the myelin layer of nerve fibers; and therefore this deterioration is the cause of serious pathologies such as multiple sclerosis (MS), leukodystrophy, disseminated acute encephalomyelitis. Cerebral or cerebrovascular ischemia is the interruption of the blood supply to the brain, thus interrupting; the flow of oxygen and nutrients needed to maintain the functioning of brain cells. The algorithm allows the differentiation between these lesions.
Brain demyelination lesions occur due to damage of the myelin layer of nerve fibers, this deterioration is the cause of pathologies such as multiple sclerosis, leukodystrophy, encephalomyelitis. Brain ischemia is the interruption of the blood supply to the brain, and the flow of oxygen and nutrients needed to maintain the correct functioning of brain cells.This project presents the results of an algorithm processing images with the the main objective of identify and differentiate between demyelination and ischemic brain diseases through the automatic detection, classification and identification of their features found in the magnetic resonance images. The sequences of images used were T1, T2, and FLAIR and with a dataset of 300 patients with and without these or other pathologies, respectively.The algorithm in this stage uses Discrete Wavelet Transform (DWT), principal component analysis (PCA) and a kernel support vector machine (SVM). The algorithm developed indicates a 75% of accuracy, for that reason, with an effective validation could be applied for the fast diagnosis and contribute to an effective treatment of these brain diseases especially in the rural places.
Background:
Molecular phylogenetic algorithms frequently disagree with the approaches considering
reproductive compatibility and morphological criteria for species delimitation. The question stems if
the resulting species boundaries from molecular, reproductive and/or morphological data are
definitively not reconcilable; or if the existing phylogenetic methods are not sensitive enough to agree
morphological and genetic variation in species delimitation.
Objectives :
We propose to DISTATIS as
an integrative framework to combine alignment-based (AB) and alignment-free (AF) distance
matrices from ITS2 sequences/structures to shed light whether Gelasinospora and Neurospora are
sister but independent genera?
Methodology:
We aimed at addressing this standing issue by
harmonizing genus-specific classification based on their ascospore morphology and ITS2 molecular
data. To validate our proposal, three phylogenetic approaches: i) traditional alignment-based, ii)
alignment-free and iii) novel distance integrative (DI)-based were comparatively evaluated on a set of
Gelasinospora and Neurospora species. All considered species have been extensively characterized at
both the morphological and reproductive levels and there are known incongruences between their
ascospore morphology and molecular data that hampers genus-specific delimitation.
Results:
Traditional AB phylogenetic analyses fail at resolving the Gelasinospora and Neurospora genera into
independent monophyletic clades following ascospore morphology criteria. In contrast, AF and DI
approaches produced phylogenetic trees that could properly delimit the expected monophyletic clades.
Conclusions:
The DI approach outperformed the AF one in the sense that it could also divide the
Neurospora species according to their reproduction mode.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.